Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial

Overview of attention for article published in Orphanet Journal of Rare Diseases, March 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 15,339 followers.

Samantha Marie Sheridan is this what you were talking about? https://t.co/VwpiEupTu2

Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a... https://t.co/Tok38AnLRx

Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multic... https://t.co/OqPpBucxf3 #EnfermedadesRaras

Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized,… https://t.co/qZnay91pkA

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.